Bibliography
- Bangham AD , HorneRW: Negative staining of phospholipids and their structure modification by surface-active agents as observed in the electron microscope.J. Mol. Biol.8, 660–668 (1964).
- Papahadjopoulos D , AllenTM, GabizonAet al.: Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.Proc. Natl Acad. Sci. USA88, 11460–11464 (1991).
- Torchilin VP : Recent advances with liposomes as pharmaceutical carriers.Nat. Rev. Drug Discov.4, 145–160 (2005).
- Sofuo S : Surface-active liposomes for targeted cancer therapy.Nanomed.2, 711–724 (2007).
- Goins B , PhillipsWT: The use of scintigraphic imaging as a tool in the development of liposome formulations.Prog. Lipid Res.40, 95–123 (2001).
- Laverman P , BrouwersAH, DamsETet al.: Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose.J. Pharmacol. Exp. Ther.293, 996–1001 (2000).
- Phillips WT , GoinsBA, BaoA: Radioactive liposomes.Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.1, 69–83 (2009).
- Phillips WT , RudolphAS, GoinsB, TimmonsJH, KlipperR, BlumhardtR: A simple method for producing a technetium-99m labeled liposome which is stable in vivo.Nucl. Med. Biol.19, 539–547(1992).
- Moghimi SM , HunterAC, MurrayJC: Long-circulating and target-specific nanoparticles: theory to practice.Pharmacol. Rev.53, 283–318 (2001).
- Klibanov AL , MaruyamaK, TorchilinVP, HuangL: Amphipatic poly(ethylene glycol)s effectively prolong the circulation time of liposome.FEBS Lett.268, 235–237 (1990).
- Woodle MC , LasicDD: Sterically stabilized liposome.Biochim. Biophys. Acta1113, 171–199 (1992).
- Phillips WT , KlipperRW, AwasthiVDet al.: Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute.J. Pharmacol. Exp. Ther.288, 665–670 (1999).
- Chellat F , MerhiY, MoreauA, Yahia L‘H: Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials26, 7260–7275 (2005).
- Zeisberger SM , OdermattB, MartyC, Zehnder-FjällmanAHM, Ballmer-HoferK, SchwendenerRA: Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach.Br. J. Cancer95, 272–281 (2006).
- Sou K , InenagaS, TakeokaS, TsuchidaE: Loading of curcumin into macrophages using lipid-based nanoparticles.Int. J. Pharm.352, 287–293 (2008).
- Wijagkanalan W , KawakamiS, TakenagaM, IgarashiR, YamashitaF, HashidaM: Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats.J. Control. Release125, 121–130 (2008).
- Espuelas S , ThumannC, HeurtaultB, SchuberF, FrischB: Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes.Bioconjug. Chem.19, 2385–2393 (2008).
- Sou K , GoinsB, TakeokaS, TsuchidaE, PhillipsWT: Selective uptake of surface-modified phospholipid vesicles by bone marrow macrophages in vivo.Biomaterials28, 2655–2666 (2007).
- Chasis JA , MohandasN: Erythroblastic islands: niches for erythropoiesis.Blood112, 470–478 (2008).
- Sou K , NaitoY, EndoT, TakeokaS, TsuchidaE: Effective encapsulation of proteins into size-controlled phospholipid vesicles using freeze-thawing and extrusion.Biotechnol. Prog.19, 1547–1552 (2003).
- Baba K , MorettiJL, WeinmannP, Senekowitsch-SchmidtkeR, ErcanMT: Tc-glutathione complex (Tc-GSH): labelling, chemical characterization and biodistribution in rats.Met. Based Drugs6, 329–336 (1999).
- Yoshida H , KawaneK, KoikeM, MoriY, UchiyamaY, NagataS: Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells.Nature437, 754–758 (2005).
- Fadeel B , QuinnP, XueD, KaganV: Fat(al) attraction: oxidized lipids act as ‘eat-me’ signals.HFSP J.1, 225–229 (2007).
- Sou K , KlipperR, GoinsB, TsuchidaE, PhillipsWT: Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute.J. Pharmacol. Exp. Ther.312, 702–709 (2005).
- Morrie E , KricunMD: Red–yellow marrow conversion: its effect on the location of some solitary bone lesions.Skeletal Radiol.14, 10–19 (1985).
- Woodburn KW , WilsonSD, FongKL, SchatzPJ, SpainhourCB, NortonD: Chronic pharmacological and safety evaluation of Hematide, a PEGylated peptidic erythropoiesis-stimulating agent, in rodents.Basic Clin. Pharmacol. Toxicol.104, 155–163 (2009).
- Dams ET , LavermanP, OyenWJet al.: Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.J. Pharmacol. Exp. Ther.292, 1071–1079 (2000).
- Hussain MM , MahleyRW, BoylesJK, LindquistPA, BrechtWJ, InnerarityTL: Chylomicron metabolism. Chylomicron uptake by bone marrow in different animal species.J. Biol. Chem.264, 17931–17938 (1989).
- Furze RC , RankinSM: The role of the bone marrow in neutrophil clearance under homeostatic conditions in the mouse.FASEB J.22, 3111–3119 (2008).
- Furze RC , RankinSM: Neutrophil mobilization and clearance in the bone marrow.Immunology125, 281–288 (2008).
- Sadahira Y , MoriM: Role of the macrophage in erythropoiesis.Pathol. Int.49, 841–848. (1999).
- Senior J , CrawleyJC, GregoriadisG: Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection.Biochim. Biophys. Acta839, 1–8 (1985).
- Szabó R , PeiserL, PlüddenmannAet al.: Uptake of branched polypeptides with poly[L-Lys] backbone by bone-marrow culture-derived murine macrophages: the role of the class A scavenger receptor.Bioconjug. Chem.16, 1442–1450 (2005).
- Moghimi SM : Exploiting bone marrow microvascular structure for drug delivery and future therapies.Adv. Drug Deliv. Rev.17, 61–73 (1995).
- Storm G , SteerenbergPA, EmmenF, van Borssum Waalkes M, Crommelin DJ: Release of doxorubicin from peritoneal macrophages exposed in vivo to doxorubicin-containing liposomes. Biochim. Biophys. Acta965, 136–145 (1988).
- Burke B , SumnerS, MaitlandN, LewisCE: Macrophages in gene therapy: cellular delivery vehicles and in vivotargets.J. Leukoc. Biol.72, 417–28 (2002).
- Ikehara Y , NiwaT, BiaoLet al.: A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle.Cancer Res.66, 8740–8748 (2006).
- Sunderkötter C , SteinbrinkK, GoebelerM, BhardwajR, SorgC: Macrophages and angiogenesis.J. Leukoc. Biol.55, 410–422 (1994).
- Hiraoka K , ZenmyoM, WatariKet al.: Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages.Cancer Sci.99, 1595–1602 (2008).